Literature DB >> 24095090

Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment.

Chi Hoon Park1, Hyeonjeong Choe, In-Young Jang, So Yeong Kwon, Muhammad Latif, Heung Kyoung Lee, Hyeon Ji Lee, Eun Hye Yang, Jeong In Yun, Chong Hak Chae, Sung Yun Cho, Sang Un Choi, Jae Du Ha, Heejung Jung, Hyoung Rae Kim, Pilho Kim, Chong Ock Lee, Chang-Soo Yun, Kwangho Lee.   

Abstract

The synthesis of bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines is described and their structure-activity-relationship to anaplastic lymphoma kinase (ALK) is presented. KRCA-0008 is selective and potent to ALK and Ack1, and displays drug-like properties without hERG liability. KRCA-0008 demonstrates in vivo efficacy comparable to Crizotinib in xenograft mice model.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ACK1; ALK; Diaminopyrimidine; Inhibitors; Kinases; N-Acetylpiperidine; NSCLC

Mesh:

Substances:

Year:  2013        PMID: 24095090     DOI: 10.1016/j.bmcl.2013.08.090

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Development of novel ACK1/TNK2 inhibitors using a fragment-based approach.

Authors:  Harshani R Lawrence; Kiran Mahajan; Yunting Luo; Daniel Zhang; Nathan Tindall; Miles Huseyin; Harsukh Gevariya; Sakib Kazi; Sevil Ozcan; Nupam P Mahajan; Nicholas J Lawrence
Journal:  J Med Chem       Date:  2015-03-17       Impact factor: 7.446

Review 2.  Latest perspectives of orally bioavailable 2,4-diarylaminopyrimidine analogues (DAAPalogues) as anaplastic lymphoma kinase inhibitors: discovery and clinical developments.

Authors:  Muhammad Latif; Zaman Ashraf; Sulman Basit; Abdul Ghaffar; Muhammad Sohail Zafar; Aamer Saeed; Sultan Ayoub Meo
Journal:  RSC Adv       Date:  2018-05-04       Impact factor: 4.036

3.  Pd-Catalyzed Difluoromethylations of Aryl Boronic Acids, Halides, and Pseudohalides with ICF2 H Generated ex Situ.

Authors:  Oliver R Gedde; Andreas Bonde; Peter I Golbaekdal; Troels Skrydstrup
Journal:  Chemistry       Date:  2022-05-03       Impact factor: 5.020

4.  Small molecule induced oligomerization, clustering and clathrin-independent endocytosis of the dopamine transporter.

Authors:  Tatiana Sorkina; Shiqi Ma; Mads Breum Larsen; Simon C Watkins; Alexander Sorkin
Journal:  Elife       Date:  2018-04-09       Impact factor: 8.140

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.